Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
Noosa News22 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General20 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News22 hours agoGrow it local | Noosa Today
-
Noosa News23 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes